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Integrin subunits present on human bladder cells displayed heterogeneous func-
tional specificity in adhesion to extracellular matrix proteins (ECM). The
non-malignant cell line (HCV29) showed significantly higher adhesion efficiency to
collagen IV, laminin (LN) and fibronectin (FN) than cancer (T24, Hu456) and v-raf
transfected (BC3726) cell lines. Specific antibodies to the 2, 5 and 1 integrin sub-
units inhibited adhesion of the non-malignant cells, indicating these integrin partici-
pation in the adhesion to ECM proteins. In contrast, adhesion of cancer cells was not
inhibited by specific antibodies to the 1 integrin subunit. Antibodies to 3 integrin in-
creased adhesion of cancer cells to collagen, LN and FN, but also of the HCV29 line
with colagen. It seems that 3 subunit plays a major role in modulation of other
integrin receptors especially in cancer cells. Differences in adhesion to ECM proteins
between the non-malignant and cancer cell lines in response to Gal and Fuc were not
evident, except for the v-raf transfected cell line which showed a distinct about 6-fold
increased adhesion to LN on addition of both saccharides. N-Acetylneuraminic acid
inhibited adhesion of all cell lines to LN and FN irrespective of their malignancy.
Many studies have attributed the altered ad-
hesive behaviour of tumour and transformed
cells to changes in the expression pattern and
affinity of their integrins (Morini et al., 2000;
Schramm et al., 2000). Most integrins are able
to bind various ligands with different affinities.
The high affinity state of an integrin for its
ligand may be a constitutive condition depend-
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ing on the cell type, or may be induced by sig-
nalling through other cells surface receptors
(Ivaska & Heino, 2000). Rapid upregulation of
the integrin function is induced by numerous
stimuli acting either from outside the cell or
from its interior (Humphries, 1996). The inter-
actions of cells with extracellular matrix (ECM)
depend on the expression and function of
integrin receptors. On the other hand, changes
in the expression and structure of carbohy-
drates may be considered as a universal fea-
ture of malignant transformation. It is known
that protein–carbohydrate interactions play a
crucial role in recognitive events. In particular,
galectins that specifically bind  galactose resi-
dues have been implicated as modulators of
cell adhesion, since they are secreted into the
extracellular space and cross-link the glyco-
conjugates on the cell surface and ECM pro-
teins, most probably laminin (LN) (Zhou &
Cummings, 1993) and fibronectin (FN) (Ozeki
et al., 1995). In accordance with the proposed
function galectins enhance (Kuwabara & Liu,
1996) or inhibit (Hadari et al., 2000) cell matrix
interactions. Carbohydrate-based recognition
occurring on the cell surface depends also on
the presence of sialic acid residues, which po-
tentially can inhibit intermolecular and inter-
cellular interactions due to their negative
charge. However, they can also act as ligands
recognised by a variety of sialic acid binding
lectins (Kim & Varki, 1997). Also sialyl Lewisa
antigens are implicated in the adhesion of hu-
man cancer cells (Ugorski & Laskowska, 2002).
The results of flow cytometry of the same hu-
man non-malignant ureter epithelium
(HCV29), malignant human bladder carci-
noma (T24, HU456) and v-raf transfected
HCV29 (BC3726) cell lines (Laidler et al.,
2000) indicated significant differences in ex-
pression of the 1 integrin subunit in cell
lines irrespective of their malignancy and
nonsignificant differences in the expression
of the 2 3 and 5 subunits between malig-
nant and non malignant cell lines. To specify
more closely the role of these integrins in the
progression of the transitional bladder cancer
we have extended our studies to the adhesion
efficiency assays of the above cell lines to col-
lagen type IV, LN and FN, using specific
anti-integrin antibodies and also three mono-
saccharides, i.e. fucose (Fuc), galactose (Gal)
and N-acetylneuraminic acid (NeuAc), affect-
ing cell adhesion.
MATERIALS AND METHODS
Chemicals. PVDF membranes were from
Millipore. Collagen IV, fibronectin, laminin,
bovine serum albumin (BSA) solution, crystal
violet, proteinase inhibitor cocktail, and
fucose were from Sigma Chemical Co. Galac-
tose and N-acetylneuraminic acid were from
Serva. All remaining chemicals were of ana-
lytical grade.
Monoclonal antibodies. The following
monoclonal antibodies (mAbs) were used: spe-
cific to the 2 (clone P1E6) and 3 (clone
P1B5) integrin subunits (DAKO); specific to
the 5 (clone CDw49e) and 1 (clone CD29/
GPIIa) subunits (Genosys Biotechnologies).
Cell lines and culture conditions. The fol-
lowing cell lines were used: non-malignant
transitional epithelial of ureter, HCV29, and
transitional cancer of ureter bladder, Hu456
(Vilien et al., 1983), T24 (HTB-4, ATCC (Bube-
nick et al., 1973)), and v-raf transfected
HCV29 line, BC3726. These cell lines were ob-
tained from the Cell Line Collection of the In-
stitute of Immunology and Experimental
Therapy, Polish Academy of Sciences
(Wroc³aw, Poland). The cell lines were cul-
tured in RPMI 1640 medium (Sigma Chemical
Co.) containing 10% fetal bovine serum (FBS)
(GibcoBRLTM or Boehringer) and antibiotics
(penicilin — 100 U/ml, streptomycin — 100
g/ml, Polfa Tarchomin, Poland). The cells
were grown in monolayers in a 95% air/5%
CO2 atmosphere at 37C in a humidified incu-
bator.
Cell adhesion assay. 96-well culture plates
(Costar) coated alternatively with 10 g/ml
collagen IV, LN or FN were blocked for 90 min
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at 37C with 1% heat-denatured BSA. Next the
wells were washed twice with phos-
phate-buffered saline (PBS) and once with
RPMI 1640 to remove the excess of BSA prior
to the addition of cells. Before the adhesion as-
say, cells were washed in serum-free medium
and starved for 30 min. Cells were trypsinized
and reseeded at a density of 5  104 cells per
well on the different matrix proteins. Cells
were allowed to adhere for 30 min at 37C in a
CO2 incubator. Non-adherent cells were re-
moved by washing three times with PBS. Ad-
herent cells were fixed for 10 min in 96% etha-
nol, washed three times in PBS, stained with
0.1% crystal violet for 25 min, washed in tap
water and air-dried. Stained cells were lysed
overnight on a shaker in 0.5% Triton X-100 to
release the dye. The absorbance at 600 nm de-
termined using an ELISA-reader (Elx 808IV
Ultra Microplate Reader, Bio Tek Instru-
ments) was proportional to cell numbers
(Kueng et al., 1989). Each data point was cal-
culated from two separate experiments per-
formed in triplicate and was expressed as the
mean ±standard deviation (S.D.). Non-speci-
fic cell adhesion as measured on BSA-coated
wells was subtracted.
For competition experiments, cells were pre-
incubated with monoclonal antibodies against
the2,3,5 or1 integrin subunits at a concen-
tration of 1.4 g/ml, 2 g/ml, 1.2 g/ml and 1.5
g/ml, respectively, on a shaker at room tem-
perature for 30 min prior to seeding on matrix
protein coated wells. After pre-incubation with
mAbs, cell viability was higher than 97%. The
antibody remained present during the assay.
Control competitions with non-specific IgG had
no effect on adhesion.
In order to study the participation of carbo-
hydrate moieties of the cell surface
glycoproteins as well as ECM proteins in the
adhesion process, we analysed the adhesion
efficiency of the cells to LN and FN in the
presence of 0.1 M Fuc, Gal or NeuAc solutions
in PBS.
Statistics. The significance of the differ-
ences between mean values were computed
using Dunkan’s new multiple range test
(*P < 0.05 or **P < 0.01).
Other methods. Protein was determined by
the Comassie Brilliant Blue-binding assay




The cell lines examined attached to collagen
IV, LN and FN with different efficiencies
(Fig. 1). The adhesion efficiency of the normal
HCV29 cells to all ECM proteins was signifi-
cantly higher than that of T24, Hu456 and
BC3726 cells, except for Hu456 and BC3726
cells adhesion to collagen IV.























Figure 1. Adhesion of human non-ma-
lignant HCV29 and malignant T24,
Hu456, and BC3726 cells to collagen
IV, laminin and fibronectin.
Cell adhesion is presented as absorbance
units (A) at 600 nm. Values are expressed
as mean ±standard deviation of two inde-
pendent experiments performed in tripli-
cate. Bars indicate S.D. and *P < 0.05 and
**P < 0.01.
Effect of monoclonal antibodies on cell
adhesion
In order to assess whether 21, 31, 51
or other integrins of the 1 integrin family
were responsible for mediating adhesion to
collagen IV, LN or FN, cell adhesion assays
were performed in the presence of specific
anti-integrin monoclonal antibodies.
As shown in Fig. 2A, mAb P1A6 to the 2
subunit inhibited Hu456 and BC3726 cells ad-
hesion to collagen IV, increased attachment of
T24 cells, but had no effect on HCV29 cells ad-
hesion level. In contrast, mAb P1B5 to 3 sub-
unit increased adherence of all cells to colla-
gen IV (Fig. 2A). On the other hand, mAb
CD29/GPIIa to 1 subunit had no effect on
any cells adhesiveness to collagen IV
(Fig. 2A). Similarly, this mAb did not affect
the ability of T24, Hu456 or BC3726 cells to
adhere to LN, but caused a decline in HCV29
cell adhesion to LN (Fig. 2B).
mAb P1B5 to the 3 subunit inhibited
HCV29 cells attachment to LN and FN
(Fig. 2B, C). However, this mAb had an oppo-
site effect on T24 and Hu456 cells adhesion
level to LN and FN, failed to affect BC3726
cell adhesion to LN and caused an increase in
the attachment to FN (Fig. 2B, C). Similarly,
mAb CDw49e to the 5 subunit inhibited
HCV29 and BC3726 cells attachment to FN
and increased T24 and Hu456 cells binding
(Fig. 2C). Incubation of cells with non-specific
IgG did not influence binding to collagen IV,
LN nor FN (not shown).
Effect of monosaccharides on cell adhesion
to LN
A significant effect was observed in the
case of NeuAc, whose presence decreased or
completely reduced adhesion to LN of all the
cell lines tested (Fig. 3A). Attachment of
HCV29 cells was also inhibited in the pres-
ence of Gal or Fuc, by about 21% and 52% of
control level (Fig. 3A). In the case of the can-
cer cell lines (T24, Hu456) the presence of
Gal or Fuc inhibited or had no effect on ad-
hesion to LN (Fig. 3A). On the other hand,
addition of Gal and Fuc caused a significant
increase in the attachment of BC3726 cells
to LN (Fig. 3A).
Effect of monosaccharides on cell adhesion
to FN
Similar as in the case of LN-binding NeuAc,
reduced adhesion of all the cell lines tested to
































































































































Figure 2. Effect of monoclonal antibodies to 2,
3, 5 and 1 integrin subunits on adhesion of
HCV29, T24, Hu456 and BC3726 cells to collagen
IV (A), laminin (B) and fibronectin (C).
Cell adhesion of cells adhering in the presence of the in-
dicated antibodies is presented relatively to control ad-
hesion (cells without additions). Each result is the aver-
age of two independent experiments performed in tripli-
cate. Relative to control taken as one. *P < 0.05 and
**P < 0.01.
FN to 0–9% of control level (Fig. 3B). Adhe-
sion of HCV29 cells was inhibited or reduced
by Gal and Fuc as in the case of LN (Fig. 3B).
Surprisingly, the cancer cells in the presence
of Gal or Fuc adhered more efficiently to FN
(Fig. 3B). The BC3726 cells behaved in the
same way as on LN being more adhesive in the
presence of both this monosaccharides.
DISCUSSION
Our results show that adherence of human
bladder non-malignant HCV29 cells to colla-
gen IV, LN and FN is higher than of cancer
cells. It is known that the interactions be-
tween cells and ECM proteins largely depend
on the expression of functional integrins on
the cell surface, mainly of the 

integrin fam-
ily (Curley et al., 1999). Adhesion of non-ma-
lignant cells was inhibited by antibodies
against the 1,,3 and5 integrin subunits
indicating that these integrins are important
receptors in non-malignant cells. These re-
sults are consistent with those of Heino
(2000) and Nykvist et al. (2000) that the 
and  integrins are high-affinity receptors
for type IV collagen, while according to
Akiyama et al. (1995) integrin 51 is the ma-
jor FN receptor for most cells. A lack or even
reverse response characteristic for cancer hu-
man bladder cells to anti-integrin antibodies
requires an explanation.
A single cell type may express multiple
integrins with an apparently redundant
ligand specificity. The functional significance
of this redundancy is not understood but it is
clear that different binding sequences are re-
cognised by separate receptors that may func-
tion cooperatively and each can lead to differ-
ent cellular response. Signalling events initi-
ated by the occupancy of one integrin can sup-
press functions associated with other inte-
grins, a process known as integrin cros-talk,
e.g. integrin v3 and 51 (Blyston et al.,
1994; 1999; Simon et al., 1997). Positive and
negative co-operation as well as trans-do-
minant inhibition have been described for sev-
eral integrins (Diaz-Gonzales et al., 1996).
Our results allow us to conclude that in the
human bladder, multiple receptors contribute
to cell adhesion to ECM proteins and each cell
line uses different repertoire of these recep-
tors, as manifested distinctly in cancer cells.
This would imply that adhesion of tumour
cells is mediated by other integrins, possibly
also from a non-1 family, e.g. by v3 which
like 51 can serve as an FN receptor.
At least fifteen different molecules have
been described as either LN receptor or
LN-binding protein, including several mem-
bers of the integrin family (Belkin & Stepp,
2000). The specificity of integrin 31 for its
ligands depends on the presence of other
integrins that may display a higher activity
















































































Figure 3. Influence of different monosaccharides
on adhesion of HCV29, T24, Hu456 and BC3726
cells to laminin (A) and fibronectin (B).
Cell adhesion was measured in the presence of 0.1 M
solutions of Gal, NeuAc or Fuc. Cell adhesion is pre-
sented relatively to control adhesion (cells without ad-
ditions). Each result is the average of two independent
experiments performed in triplicate. Relative to con-
trol taken as one. *P < 0.05 or **P < 0.01.
for the same ligands (Kreidberg, 2000;
Laplantine et al., 2000). There is growing
amount of evidence that integrin 31
transdominantly regulates integrin 61 in
mouse keratinocytes (Hodivala-Dilke et al.,
1998; Laplantine et al., 2000) or regulates neg-
atively integrin 21 in human breast carci-
noma cell lines (Lichtner et al., 1998). Our re-
sults confirmed the major role for the 31
integrin in modulating other adhesion recep-
tors especially in the case of cancer cell lines
like T24 and Hu456. However, the mechanism
of the postulated shift or cooperation in
integrins interaction in malignant cells re-
mains unknown.
Besides, although integrin-mediated adhe-
sion to FN and LN is based on interaction of
specific amino-acid residues, the strength of
the binding may be modulated by various fac-
tors including glycosylation of integrins
(Chammas et al., 1993; Zheng et al., 1994),
glycosylation status of ECM proteins (Zheng
& Hakomori, 2000) as well as carbohy-
drate–carbohydrate interactions (Wang et al.,
2001).
We observed uniform decrease of adhesion
of all the cell lines to LN and FN in the pres-
ence of NeuAc. These results suggest the par-
ticipation of NeuAc-bearing glycans in the ad-
hesion to LN and FN regardless of cell type.
The high sensitivity of all cell lines to NeuAc
does not allow one to consider inhibition of ad-
hesion by NeuAc as a factor discriminating
non-malignant from malignant cell lines. Ac-
cording to Morgenthaler et al. (1990) and Den-
nis (1991) NeuAc affects attachment to ECM
proteins either by their masking or as a recog-
nition determinant (Morgenthaler et al., 1990;
Dennis, 1991). Also in the case of FN it can
not be excluded that sialic acid competes with
polysialic acid, a very important component of
5 integrin oligosacccharides participating in
adhesion to this ECM protein as has recently
been shown (Nadanaka et al., 2001).
The alterations in the adhesion efficiencies
of the cell lines in response to Gal and Fuc
were cell- and ligand-dependent. The presence
of Gal or Fuc decreased adhesion efficiency to
LN in the non-malignant HCV29 and T24 ma-
lignant cells, while it was increased in BC3726
cells. LN is a heavily glycosylated molecule
with only N-linked complex-type oligosaccha-
rides containing poly-N-acetyllactosamine
units. Due to its unique glycosylation pattern
LN can be also recognised by cell surface  1-4
galactosyltransferase and several members of
the galactoside-binding lectin family (Cham-
mas et al., 1994). On the other hand, LN may
function as a lectin, recognising carbohydrate
moieties of the receptor as it has been shown
by Chammas et al. (1991) in metastatic muri-
ne melanoma.
Ono et al. (2000) have found that LN or
FN-dependent adhesion in Krieger’s D14 cells
was enhanced significantly in the presence of
Gal. Tunicamycin significantly inhibited adhe-
sion to LN but only slightly affected cell adhe-
sion to collagen IV of metastatic melanoma
cell lines (Bironaite et al., 2000). On the other
hand, mouse myoblasts did not distinguish be-
tween glycosylated and unglycosylated LN
substrates indicating that LN carbohydrates
are not implicated in those cellular responses
(Kostrominova & Tanzer, 1995). These facts
although controversial, suggest that glyco-
sylation of LN as well as of surface proteins
are important in adhesion events, but as it
was shown in our study it takes place in a
cell-type dependent manner.
The distinctly different adhesion of BC3726
cells to LN and FN in the presence of
monosaccharides compared with the other
cell lines may suggest significant changes in
properties of the cellular membrane proteins
due to v-raf transfection.
From all these results we can conclude that
the behaviour of non-malignant bladder cells
differs significantly from that of cancer ones
with respect to the integrins used as well as
the participation of saccharides in adhesion.
The cancer cells showed a more veriable pat-
tern of cell adhesion.
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